FABP4 and Obesity: In the context of obesity, we anticipate that the elevated levels of circulating FABP4, combined with increased lipid content in adipocytes, uncontrolled lipolysis, and ectopic lipid deposition in other organs (Maeda et al, 2005), may collectively contribute to the heightened disease severity.